Novel biomarkers
OwnerSven KOCH, Henoch HONG +1inventors
InventorsSven KOCH, Henoch HONG, Mariola FOTIN-MLECZEK
Life of this patent
Estimating the term…
Loading patent…
OwnerSven KOCH, Henoch HONG +1inventors
InventorsSven KOCH, Henoch HONG, Mariola FOTIN-MLECZEK
Estimating the term…
The present invention relates to methods of diagnosing, monitoring of a subject or determining the prognosis of a subject. In particular, the invention relates to a method of determining the prognosis of a cancer patient comprising the steps (a) determining the expression level of at least one marker gene selected from the group consisting of the marker genes as described herein in a sample of the cancer patient to obtain a gene expression profile; (b) determining the prognosis of the cancer patient based on the gene expression profile obtained in step (a). In addition, the present invention refers to kits, diagnostic compositions devices and microarrays for determining at least one marker gene and uses thereof.
A method of determining the prognosis of a patient comprising the steps of
Method according to any one of the preceding claims, wherein at least 10 additional marker genes, preferably at least 20 additional marker genes, more preferably at least 70 additional marker genes are selected from table 2.
Method according to any one of the preceding claims, wherein at least 10 additional marker genes, preferably at least 20 additional marker genes are selected from table 3.
Method according to any one of the preceding claims, wherein the expression level of at least one marker gene is measured before administration and/or after administration of at least one dose of a therapeutic agent.
Method according to any one of the preceding claims, wherein the sample of the patient comprises peripheral blood mono-nuclear cells (PBMCs).
Method according to any one of the preceding claims, wherein in step (b) a hierarchical clustering algorithm is applied.
Kit, diagnostic composition or device for the analysis of at least one marker gene set out in table 1 comprising at least one primer and/or probe selective for determining the expression level of at least one marker gene set out in table 1.
Microarray, comprising at least one probe selective for determining the expression level of at least one marker gene set out in table 1.
A method of determining the prognosis of a patient comprising the steps of
Kit, diagnostic composition or device for the analysis of at least one marker gene set out in table 11 comprising at least one primer and/or probe selective for determining the expression level of at least one marker gene set out in table 11.
Microarray, comprising at least one probe selective for determining the expression level of at least one marker gene set out in table 11.
A method of determining the prognosis of a patient comprising the steps of
Kit, diagnostic composition or device for the analysis of at least one marker gene set out in table 6 comprising at least one primer and/or probe selective for determining the expression level of at least one marker gene set out in table 6.
Microarray, comprising at least one probe selective for determining the expression level of at least one marker gene set out in table 6.
Dependencies are inferred from the claim text.